Today’s biotech news includes fertility services for Casgevy patients, Trump’s pick for VP, and biotech’s rebound amid inflation cooling.
Roche looks to have a competitive GLP-1 drug – STAT News
Categories:
Related Post
Femasys Secures Patent Protection for FemaSeed Fertility Treatment Through 2044 – Stock TitanFemasys Secures Patent Protection for FemaSeed Fertility Treatment Through 2044 – Stock Titan
Femasys strengthens IP portfolio with new USPTO patent allowance for FemaSeed® Intratubal Insemination, extending protection for its innovative …
Impacts of common medical condition among women, uterine fibroids, remain unknownImpacts of common medical condition among women, uterine fibroids, remain unknown
01:04Many women are asymptomatic but others experience fertility issues, intense pain and heavy periods. 01:11The medical doctors said, oh that’s …
Ancestral lineages of dietary exposure to an endocrine disrupting chemical drive distinct … – NatureAncestral lineages of dietary exposure to an endocrine disrupting chemical drive distinct … – Nature
… fertility. To test whether generations of Drosophila melanogaster born from parents exposed to a common dietary EDC, equol, could recover …